markennovy Archives - mark'ennovy

A study looks at the efficacy of MYLO: a monthly disposable silicone hydrogel contact lens designed with BHVI‘s patented EDOF technology to slow the progression of myopia. EDOF technology has previously been studied in terms of visual performance and efficacy in slowing myopic progression. Also, some data on short-term visual effects of MYLO have recently […]
23
May 2022

mark’ennovy specialises in multifocal soft contact lenses for all types of presbyopic eyes and levels of astigmatism. Did you know that… Holden et al. estimated that the global prevalence of presbyopia is increasing to 1.8 billion people by 2050? This is the reason why contact lenses for presbyopia are gaining momentum: Contact lenses, in general, […]
14
January 2022

Why is presbyopia such a big deal? Currently, in Europe alone, there are around 340 million people over the age of 45 in need of some degree of correction for near vision1. Studies estimate that 1.8 billion people worldwide will be presbyopic by 20501. However, considering contact lens wear, presbyopia tends to increase patient dropout. […]
19
March 2019

The Brien Holden Vision Institute Ltd, a leading global translational research and vision correction centre, and mark’ennovy, the No.1 independent manufacturer of premium precision soft contact lenses, have signed a second licensing agreement to bring to market a moulded soft contact lens with Brien Holden Vision Institute’s patented Extended Depth of Focus (EDOF) design to […]
4
March 2019

Accelerating global development for the leader in custom fit extended range contact lenses 28 September, 2018 Mark’ennovy Personalized Care, European-based provider of precision contact lenses, is pleased to announce the completion of a significant debt and equity funding package. Bond Capital Partners, a London based, independent investor and advisor to small and medium-sized businesses […]
17
October 2018

Every year, World Retinitis Pigmentosa Day is celebrated on the last Sunday of September to create awareness for this disorder, the consciousness level for which is extremely low in society today. Retinitis Pigmentosa (RP) is a group of rare genetic disorders affecting the cells in the retina (photoreceptors) causing their breakdown and subsequent loss. […]
29
September 2018

Myopia: An Epidemic that Affects Us Locally. Over the last few years, myopia has become a trending topic among eye care academics, practitioners and contact lens manufacturers alike. Why is this? What is the big deal about myopia? For most eye care professionals, myopia is just a refractive error that they confront every day: […]
4
May 2018

Industry communication focuses on digital devices as the primary source of harmful blue light. The sun, however, is the light source we should be most concerned about. It is ten times more powerful than any artificial light source (1), and the leading source of harmful blue and UV light (280 – 450nm). The sun […]
26
February 2018

mark’ennovy: in constant pursuit of the most eye-opening contact lens wearing experience As part of our philosophy to continuously improve the technology and design behind our contact lenses, we are pleased to announce the introduction of a new edge design, resulting in better comfort for our complete range of Blu:gen and Saphir Rx monthly contact […]
1
February 2018

The Brien Holden Vision Institute, a Leading Translational Research Vision Correction Centre in the world, and mark’ennovy, the No.1 independent manufacturer of premium monthly replacement Contact Lenses, are proud to announce their Strategic Partnership, having signed a worldwide exclusive licensing agreement to bring to market a new design soft contact lenses, in Silicone Hydrogel, specifically […]
19
September 2017